Ocugen (OCGN) Gains from Investment Securities (2016 - 2019)
Ocugen (OCGN) posted Gains from Investment Securities of $5000.0 for Q2 2019, down 99.64% on a QoQ basis from $1.4 million in Q1 2019, and up 100.14% year-over-year from $2498.2 in Q2 2018.
Ocugen (OCGN) Gains from Investment Securities (2016 - 2019) Analysis & Trends
Ocugen's Gains from Investment Securities history runs 4 years deep, the most recent figure standing at $5000.0 for Q2 2019.
- Quarterly Gains from Investment Securities rose 100.14% year-over-year to $5000.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was -$24.4 million (down 486.11% YoY) and the FY2018 annual result came in at -$20.6 million, down 1490.08% from the prior year.
- Gains from Investment Securities was $5000.0 for Q2 2019 at Ocugen, down from $1.4 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $8.8 million in Q1 2018 and bottomed at -$17.8 million in Q3 2018.
- A 4-year average of -$2.9 million and a median of $70000.0 in 2017 frame the typical range for Gains from Investment Securities.
- Peak annual rise in Gains from Investment Securities reached 3153.9% in 2018, while the deepest fall reached 6708.18% in 2018.
- Ocugen's Gains from Investment Securities stood at -$17.0 million in 2016, then surged by 104.77% to $809000.0 in 2017, then slumped by 1098.39% to -$8.1 million in 2018, then surged by 100.06% to $5000.0 in 2019.
- Business Quant data shows OCGN's Gains from Investment Securities at $5000.0 in Q2 2019, $1.4 million in Q1 2019, and -$8.1 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ocugen | 415.98 Mn | 415.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 5,000.00 |
| Jun 30, 2019 | 5,000.00 |
| Mar 31, 2019 | 1.41 Mn |
| Mar 31, 2019 | 1.41 Mn |
| Dec 31, 2018 | -8.08 Mn |
| Dec 31, 2018 | -8.08 Mn |
| Sep 30, 2018 | -17.78 Mn |
| Sep 30, 2018 | -17.78 Mn |
| Jun 30, 2018 | -3.50 Mn |
| Jun 30, 2018 | -3.50 Mn |
| Mar 31, 2018 | 8.75 Mn |
| Mar 31, 2018 | 8.75 Mn |
| Dec 31, 2017 | 809,000.00 |
| Dec 31, 2017 | 809,000.00 |
| Sep 30, 2017 | 269,000.00 |
| Sep 30, 2017 | 269,000.00 |
| Jun 30, 2017 | 135,000.00 |
| Jun 30, 2017 | 135,000.00 |
| Mar 31, 2017 | 269,000.00 |
| Mar 31, 2017 | 269,000.00 |